These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12154404)

  • 1. The study of aberrant methylation in cancer via restriction landmark genomic scanning.
    Smiraglia DJ; Plass C
    Oncogene; 2002 Aug; 21(35):5414-26. PubMed ID: 12154404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restriction landmark genomic scanning: analysis of CpG islands in genomes by 2D gel electrophoresis.
    Costello JF; Hong C; Plass C; Smiraglia DJ
    Methods Mol Biol; 2009; 507():131-48. PubMed ID: 18987812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors.
    Zardo G; Tiirikainen MI; Hong C; Misra A; Feuerstein BG; Volik S; Collins CC; Lamborn KR; Bollen A; Pinkel D; Albertson DG; Costello JF
    Nat Genet; 2002 Nov; 32(3):453-8. PubMed ID: 12355068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies.
    Yu L; Liu C; Bennett K; Wu YZ; Dai Z; Vandeusen J; Opavsky R; Raval A; Trikha P; Rodriguez B; Becknell B; Mao C; Lee S; Davuluri RV; Leone G; Van den Veyver IB; Caligiuri MA; Plass C
    Genomics; 2004 Oct; 84(4):647-60. PubMed ID: 15475242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
    Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
    Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
    Esteller M
    Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islands.
    Dai Z; Weichenhan D; Wu YZ; Hall JL; Rush LJ; Smith LT; Raval A; Yu L; Kroll D; Muehlisch J; Frühwald MC; de Jong P; Catanese J; Davuluri RV; Smiraglia DJ; Plass C
    Genome Res; 2002 Oct; 12(10):1591-8. PubMed ID: 12368252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell type-specific methylation profiles occurring disproportionately in CpG-less regions that delineate developmental similarity.
    Sakamoto H; Suzuki M; Abe T; Hosoyama T; Himeno E; Tanaka S; Greally JM; Hattori N; Yagi S; Shiota K
    Genes Cells; 2007 Oct; 12(10):1123-32. PubMed ID: 17903172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications.
    Rush LJ; Plass C
    Anal Biochem; 2002 Aug; 307(2):191-201. PubMed ID: 12202234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restriction landmark genomic scanning (RLGS-M)-based genome-wide scanning of mouse liver tumors for alterations in DNA methylation status.
    Akama TO; Okazaki Y; Ito M; Okuizumi H; Konno H; Muramatsu M; Plass C; Held WA; Hayashizaki Y
    Cancer Res; 1997 Aug; 57(15):3294-9. PubMed ID: 9242463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene silencing by DNA methylation in haematological malignancies.
    Boultwood J; Wainscoat JS
    Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new class of tissue-specifically methylated regions involving entire CpG islands in the mouse.
    Suzuki M; Sato S; Arai Y; Shinohara T; Tanaka S; Greally JM; Hattori N; Shiota K
    Genes Cells; 2007 Dec; 12(12):1305-14. PubMed ID: 18076568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction landmark genome scanning.
    Costello JF; Smiraglia DJ; Plass C
    Methods; 2002 Jun; 27(2):144-9. PubMed ID: 12095273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs.
    Frühwald MC; O'Dorisio MS; Dai Z; Rush LJ; Krahe R; Smiraglia DJ; Pietsch T; Elsea SH; Plass C
    Genes Chromosomes Cancer; 2001 Jan; 30(1):38-47. PubMed ID: 11107174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide and locus-specific DNA hypomethylation in G9a deficient mouse embryonic stem cells.
    Ikegami K; Iwatani M; Suzuki M; Tachibana M; Shinkai Y; Tanaka S; Greally JM; Yagi S; Hattori N; Shiota K
    Genes Cells; 2007 Jan; 12(1):1-11. PubMed ID: 17212651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA hypermethylation: when tumour suppressor genes go silent.
    Garinis GA; Patrinos GP; Spanakis NE; Menounos PG
    Hum Genet; 2002 Aug; 111(2):115-27. PubMed ID: 12189484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels.
    Smiraglia DJ; Frühwald MC; Costello JF; McCormick SP; Dai Z; Peltomäki P; O'Dorisio MS; Cavenee WK; Plass C
    Genomics; 1999 Jun; 58(3):254-62. PubMed ID: 10373323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation in cancer: too much, but also too little.
    Ehrlich M
    Oncogene; 2002 Aug; 21(35):5400-13. PubMed ID: 12154403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation, imprinting and cancer.
    Plass C; Soloway PD
    Eur J Hum Genet; 2002 Jan; 10(1):6-16. PubMed ID: 11896451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.